By Professor Bruce James Brew

Journal articles

Chaganti JR; Talekar TK; Brew BJ, 2025, 'Asymmetrical glymphatic dysfunction in patients with long Covid associated neurocognitive impairment- correlation with BBB disruption', BMC Neurology, 25, http://dx.doi.org/10.1186/s12883-025-04133-4

Branton WG; Zhang N; Cohen EA; Brew BJ; Gill MJ; Gelman BB; Kong L; Power C, 2025, 'Brain RNA profiling highlights multiple disease pathways in persons with HIV-associated neurocognitive disorder', AIDS, 39, pp. 496 - 507, http://dx.doi.org/10.1097/QAD.0000000000004116

Jia FF; Brew BJ, 2025, 'Neuropathogenesis of acute HIV: mechanisms, biomarkers, and therapeutic approaches.', Curr Opin HIV AIDS, http://dx.doi.org/10.1097/COH.0000000000000923

Macfarlane S; Grimmer T; Teo K; O'Brien TJ; Woodward M; Grunfeld J; Mander A; Brodtmann A; Brew BJ; Morris P; Short C; Kurrle S; Lai R; Bharadwaj S; Drysdale P; Sturm J; Lewis SJG; Barton D; Kalafatis C; Sharif S; Perry R; Mannering N; MacSweeney JE; Pearson S; Evans C; Krishna V; Thompson A; Munisamy M; Bhatt N; Asher A; Connell S; Lynch J; Rutgers SM; Dautzenberg PL; Prins N; Oschmann P; Frölich L; Tacik P; Peters O; Wiltfang J; Henri-Bhargava A; Smith E; Pasternak S; Frank A; Chertkow H; Ingram J; Hsiung GYR; Brittain R; Tartaglia C; Cohen S; Villa LM; Gordon E; Jubault T; Guizard N; Tucker A; Kaufmann WE; Jin K; Chezem WR; Missling CU; Sabbagh MN, 2025, 'Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial', The journal of prevention of Alzheimer's disease, 12, pp. 100016, http://dx.doi.org/10.1016/j.tjpad.2024.100016

Chan OKL; Zhang J; Brew BJ, 2025, 'Cerebellar stroke secondary to ovarian stimulation and patent foramen ovale', Internal Medicine Journal, 55, pp. 167 - 168, http://dx.doi.org/10.1111/imj.16622

Ayton S; Barton D; Brew B; Brodtmann A; Clarnette R; Desmond P; Devos D; Ellis KA; Fazlollahi A; Fradette C; Goh AMY; Kalinowski P; Kyndt C; Lai R; Lim YY; Maruff P; O'Brien TJ; Rowe C; Salvado O; Schofield PW; Spino M; Tricta F; Wagen A; Williams R; Woodward M; Bush AI, 2025, 'Deferiprone in Alzheimer Disease: A Randomized Clinical Trial', JAMA neurology, 82, pp. 11 - 18, http://dx.doi.org/10.1001/jamaneurol.2024.3733

Cysique LA; Levin J; Howard C; Taylor J; Rule J; Costello J; Bruning J; Njeri P; Mullens AB; Wright E; Gouse H; Daken K; Trunfio M; Aung HL; Robbins RN; Ferraris CM; Muñoz-Moreno JA; Woods SP; Moore DJ; Power C; Wong PL; Hasmukharay K; Nyamayaro P; Vera J; Rajasuriar R; Heaton RK; Goodkin K; Letendre S; Ellis RJ; Brew BJ; Rourke SB, 2025, 'Fostering healthy cognitive ageing in people living with HIV', The Lancet HIV, 12, pp. e71 - e80, http://dx.doi.org/10.1016/S2352-3018(24)00248-0

Phetsouphanh C; Jacka B; Ballouz S; Jackson KJL; Wilson DB; Manandhar B; Klemm V; Tan HX; Wheatley A; Aggarwal A; Akerman A; Milogiannakis V; Starr M; Cunningham P; Turville SG; Kent SJ; Byrne A; Brew BJ; Darley DR; Dore GJ; Kelleher AD; Matthews GV, 2024, 'Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-47720-8

Malepathirana T; Senanayake D; Gautam V; Engel M; Balez R; Lovelace MD; Sundaram G; Heng B; Chow S; Marquis C; Guillemin GJ; Brew B; Jagadish C; Ooi L; Halgamuge S, 2024, 'Visualization of incrementally learned projection trajectories for longitudinal data', Scientific Reports, 14, http://dx.doi.org/10.1038/s41598-024-63511-z

Zeng G; Krishnamurthy S; Pires AS; Guller A; Chaganti J; Tun N; Lockart I; Montagnese S; Brew B; Guillemin GJ; Danta M; Heng B, 2024, 'Activation of the kynurenine pathway identified in individuals with covert hepatic encephalopathy', Hepatology Communications, 8, http://dx.doi.org/10.1097/HC9.0000000000000559

Dehhaghi M; Heydari M; Panahi HKS; Lewin SR; Heng B; Brew BJ; Guillemin GJ, 2024, 'The roles of the kynurenine pathway in COVID-19 neuropathogenesis', Infection, 52, pp. 2043 - 2059, http://dx.doi.org/10.1007/s15010-024-02293-y

Eddine JJ; Angelovich TA; Zhou J; Byrnes SJ; Tumpach C; Saraya N; Chalmers E; Shepherd RA; Tan A; Marinis S; Gorry PR; Estes JD; Brew BJ; Lewin SR; Telwatte S; Roche M; Churchill MJ, 2024, 'HIV transcription persists in the brain of virally suppressed people with HIV', PLoS Pathogens, 20, http://dx.doi.org/10.1371/journal.ppat.1012446

Vance DE; Brew BJ, 2024, 'Plasma neurofilament light chain protein predicts greater brain-age gap, cognition, and cardiovascular risk in people with HIV', AIDS, 38, pp. 1081 - 1083, http://dx.doi.org/10.1097/QAD.0000000000003880

Cysique LA; Brew BJ; Bruning J; Byrd D; Costello J; Daken K; Ellis RJ; Fazeli PL; Goodkin K; Gouse H; Heaton RK; Letendre S; Levin J; Aung HL; Mindt MR; Moore D; Mullens AB; de Almeida SM; Muñoz-Moreno JA; Power C; Robbins RN; Rule J; Rajasuriar R; Savin MJ; Taylor J; Trunfio M; Vance DE; Wong PL; Woods SP; Wright EJ; Rourke SB, 2024, 'Cognitive criteria in HIV: greater consensus is needed', Nature Reviews Neurology, 20, pp. 127 - 128, http://dx.doi.org/10.1038/s41582-024-00927-1

Summers BS; Thomas Broome S; Pang TWR; Mundell HD; Koh Belic N; Tom NC; Ng ML; Yap M; Sen MK; Sedaghat S; Weible MW; Castorina A; Lim CK; Lovelace MD; Brew BJ, 2024, 'A Review of the Evidence for Tryptophan and the Kynurenine Pathway as a Regulator of Stem Cell Niches in Health and Disease', International Journal of Tryptophan Research, 17, pp. 11786469241248287, http://dx.doi.org/10.1177/11786469241248287

Chaganti J; Poudel G; Cysique LA; Dore GJ; Kelleher A; Matthews G; Darley D; Byrne A; Jakabek D; Zhang X; Lewis M; Jha N; Brew BJ, 2024, 'Blood brain barrier disruption and glutamatergic excitotoxicity in post-acute sequelae of SARS COV-2 infection cognitive impairment: potential biomarkers and a window into pathogenesis', Frontiers in Neurology, 15, http://dx.doi.org/10.3389/fneur.2024.1350848

Machlitt‐Northen S; Abdelkarim A; Bailey C; Budda B; Bombois S; Brew B; Brintziki D; Burgess B; Cohen S; Ganji G; Germani M; Inman D; Jayabalan T; Mummery CJ; Park L; Parker C; Romano G; Sadowski M; Salvadore G; Lai RYK, 2024, 'PROGRESS‐AD: a phase 2 study to evaluate efficacy and safety of GSK4527226 (AL101), an anti‐sortilin monoclonal antibody, in patients with early Alzheimer’s disease', Alzheimer's & Dementia, 20, http://dx.doi.org/10.1002/alz.090247

Brew BJ; Clifford DB, 2023, 'Antiretroviral therapy intensification for HIV-associated neurocognitive disorder?', AIDS, 37, pp. 2095 - 2096, http://dx.doi.org/10.1097/QAD.0000000000003694

Lewthwaite H; Byrne A; Brew B; Gibson PG, 2023, 'Treatable traits for long COVID', Respirology, 28, pp. 1005 - 1022, http://dx.doi.org/10.1111/resp.14596

Angelovich TA; Cochrane CR; Zhou J; Tumpach C; Byrnes SJ; Jamal Eddine J; Waring E; Busman-Sahay K; Deleage C; Jenkins TA; Hearps AC; Turville S; Gorry PR; Lewin SR; Brew BJ; Estes JD; Roche M; Churchill MJ, 2023, 'Regional Analysis of Intact and Defective HIV Proviruses in the Brain of Viremic and Virally Suppressed People with HIV', Annals of Neurology, 94, pp. 798 - 802, http://dx.doi.org/10.1002/ana.26750

Chaganti J; Gates TM; Brew BJ, 2023, 'Reversible large-scale network disruption correlates with neurocognitive improvement in HIV-associated minor neurocognitive disorder with combined anti-retroviral therapy intensification: a prospective longitudinal resting-state functional magnetic resonance imaging study', Neurological Sciences, 44, pp. 3261 - 3269, http://dx.doi.org/10.1007/s10072-023-06783-z

Braidy N; Brew BJ; Inestrosa NC; Chung R; Sachdev P; Guillemin GJ, 2023, 'Retraction Note to: Changes in Cathepsin D and Beclin-1 mRNA and protein expression by the excitotoxin quinolinic acid in human astrocytes and neurons (Metabolic Brain Disease, (2014), 29, 3, (873-883), 10.1007/s11011-014-9557-9)', Metabolic Brain Disease, 38, pp. 2197, http://dx.doi.org/10.1007/s11011-023-01241-3

Cysique LA; Jakabek D; Bracken SG; Allen-Davidian Y; Heng B; Chow S; Dehhaghi M; Staats Pires A; Darley DR; Byrne A; Phetsouphanh C; Kelleher A; Dore GJ; Matthews GV; Guillemin GJ; Brew BJ, 2023, 'The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC', Annals of Clinical and Translational Neurology, 10, pp. 1338 - 1352, http://dx.doi.org/10.1002/acn3.51825

Speck P; MacKenzie J; Bull RA; Slobedman B; Drummer H; Fraser J; Herrero L; Helbig K; Londrigan S; Moseley G; Prow N; Hansman G; Edwards R; Ahlenstiel C; Abendroth A; Tscharke D; Hobson-Peter J; Kriiger-Loteri R; Parry R; Marsh G; Harding E; Jacques DA; Gartner MJ; Lee WS; McAuley J; Vaz P; Sainsbury F; Tate MD; Sinclair J; Imrie A; Rawlinson S; Harman A; Carr JM; Monson EA; Hibma M; Mahony TJ; Tu T; Center RJ; Shrestha LB; Hall R; Warner M; Ward V; Anderson DE; Eyre NS; Netzler NE; Peel AJ; Revill P; Beard M; Legione AR; Spencer AJ; Idris A; Forwood J; Sarker S; Purcell DFJ; Bartlett N; Deerain JM; Brew BJ; Asgari S; Farrell H; Khromykh A; Tuipulotu DE; Anderson D; Mese S; Tayyar Y; Edenborough K; Uddin JM; Hussain A; Daymond CJI; Agius J; Johnson KN; Shirmast P; Abedinzadeshahri M; MacDiarmid R; Ashley CL; Laws J; Furfaro LL; Burton TD; Johnson SMR; Telikani Z; Petrone M; Roby JA; Samer C; Suhrbier A; Van Der Kamp A; Cunningham A; Donato C; Mahar J; Black WD; Vasudevan S; Lenchine R; Spann K; Rawle DJ; Rudd P; Neil J; Kingston R; Newsome TP; Kim KW; Mak J; Lowry K; Bryant N, 2023, 'Statement in Support of: "Virology under the Microscope - a Call for Rational Discourse"', mSphere, 8, http://dx.doi.org/10.1128/msphere.00165-23

Speck P; Mackenzie J; Bull RA; Slobedman B; Drummer H; Fraser J; Herrero L; Helbig K; Londrigan S; Moseley G; Prow N; Hansman G; Edwards R; Ahlenstiel C; Abendroth A; Tscharke D; Hobson-Peters J; Kriiger-Loterio R; Parry R; Marsh G; Harding E; Jacques DA; Gartner MJ; Lee WS; McAuley J; Vaz P; Sainsbury F; Tate MD; Sinclair J; Imrie A; Rawlinson S; Harman A; Carr JM; Monson EA; Hibma M; Mahony TJ; Tu T; Center RJ; Shrestha LB; Hall R; Warner M; Ward V; Anderson DE; Eyre NS; Netzler NE; Peel AJ; Revill P; Beard M; Legione AR; Spencer AJ; Idris A; Forwood J; Sarker S; Purcell DFJ; Bartlett N; Deerain JM; Brew BJ; Asgari S; Farrell H; Khromykh A; Tuipulotu DE; Anderson D; Mese S; Tayyar Y; Edenborough K; Uddin JM; Hussain A; Daymond CJI; Agius J; Johnson KN; Shirmast P; Abedinzadeshahri M; MacDiarmid R; Ashley CL; Laws J; Furfaro LL; Burton TD; Johnson SMR; Telikani Z; Petrone M; Roby JA; Samer C; Suhrbier A; Van Der Kamp A; Cunningham A; Donato C; Mahar J; Black WD; Vasudevan S; Lenchine R; Spann K; Rawle DJ; Rudd P; Neil J; Kingston R; Newsome TP; Kim KW; Mak J; Lowry K; Bryant N, 2023, 'Statement in Support of: “Virology under the Microscope—a Call for Rational Discourse”', mBio, 14, http://dx.doi.org/10.1128/mbio.00815-23

Brodtmann A; Darby D; Oboudiyat C; Mahoney CJ; Le Heron C; Panegyres PK; Brew B, 2023, 'Assessing preparedness for Alzheimer disease-modifying therapies in Australasian health care systems', Medical Journal of Australia, 218, pp. 247 - 249, http://dx.doi.org/10.5694/mja2.51880

Hu G; Brew BJ, 2023, 'Extracellular vesicle small noncoding RNAs: A window into pathogenesis and diagnosis', AIDS, 37, pp. 849 - 850, http://dx.doi.org/10.1097/QAD.0000000000003517

Aung HL; Bloch M; Vincent T; Mao L; Brew BJ; Cysique LA, 2023, 'Low incidence of advanced neurological burden but high incidence of age-related conditions that are dementia risk factors in aging people living with HIV: a data-linkage 10-year follow-up study', Journal of NeuroVirology, 29, pp. 141 - 155, http://dx.doi.org/10.1007/s13365-022-01104-0

Chaganti J; Zeng G; Tun N; Lockart I; Abdelshaheed C; Cysique L; Montagnese S; Brew BJ; Danta M, 2023, 'Novel magnetic resonance KTRANS measurement of blood-brain barrier permeability correlated with covert HE', Hepatology Communications, 7, http://dx.doi.org/10.1097/HC9.0000000000000079

Sen MK; Hossain MJ; Mahns DA; Brew BJ, 2023, 'Validity of serum neurofilament light chain as a prognostic biomarker of disease activity in multiple sclerosis', Journal of Neurology, 270, pp. 1908 - 1930, http://dx.doi.org/10.1007/s00415-022-11507-y

Aung HL; Alagaratnam J; Chan P; Chow FC; Joska J; Falutz J; Letendre SL; Lin W; Muñoz-Moreno JA; Cinque P; Taylor J; Brew B; Winston A, 2023, 'Cognitive Health in Persons with Human Immunodeficiency Virus: The Impact of Early Treatment, Comorbidities, and Aging', Journal of Infectious Diseases, 227, pp. S38 - S47, http://dx.doi.org/10.1093/infdis/jiac388

Byrnes SJ; Busman-Sahay K; Angelovich TA; Younger S; Taylor-Brill S; Nekorchuk M; Bondoc S; Dannay R; Terry M; Cochrane CR; Jenkins TA; Roche M; Deleage C; Bosinger SE; Paiardini M; Brew BJ; Estes JD; Churchill MJ, 2023, 'Chronic immune activation and gut barrier dysfunction is associated with neuroinflammation in ART-suppressed SIV+ rhesus macaques', PLoS Pathogens, 19, http://dx.doi.org/10.1371/journal.ppat.1011290

Cysique LA; Brew BJ, 2023, 'Is neurocognitive ageing accelerated in virally suppressed people with HIV and multimorbidity?', Brain, 146, pp. 801 - 802, http://dx.doi.org/10.1093/brain/awad035

Maamary J; Maddocks S; Barnett Y; Wong S; Rodriguez M; Hueston L; Jeoffreys N; Eden JS; Dwyer DE; Floyd T; Plit M; Kok J; Brew B, 2023, 'New Detection of Locally Acquired Japanese Encephalitis Virus Using Clinical Metagenomics, New South Wales, Australia', Emerging Infectious Diseases, 29, pp. 627 - 630, http://dx.doi.org/10.3201/eid2903.220632

Florian H; Wang D; Arnold SE; Boada M; Guo Q; Jin Z; Zheng H; Fisseha N; Kalluri HV; Rendenbach-Mueller B; Budur K; Gold M; Aware Investigators T; Acosta L; Ala T; Amadoru S; Apter J; Arnold S; Boada-Rovira M; Boerjesson-Hanson A; Bond W; Borrie M; Bottini G; Brew B; Brody M; Burke J; Burns J; Chiari A; Clarnette R; Cohen S; Farlow M; Fishman S; Foster N; Frederiksen K; Frisoni G; Gilchrist N; Gitelman D; Goodman I; Gordon M; Graff-Radford N; Hallikainen M; Ivanoiu A; Jicha G; Jonsson M; Kerwin D; Koek D; Lah J; Lall A; Lee E; Leger G; Ljubenkov P; Marra C; Martinez-Lage P; Masdeu J; McGinnis S; Mecocci P; Morris P; Nash M; Perrin A; Pierce A; Riesenberg R; Rinne J; Del Valle RS; Scarpini E; Schulz P; Schwartz R; Smith A; Spann B; Van Snick S; Vandenberghe R; Verghese C; Villarejo A; Wu C-K, 2023, 'Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study', BRAIN, 146, pp. 2275 - 2284, http://dx.doi.org/10.1093/brain/awad024

Aung HL; Siefried KJ; Gates TM; Brew BJ; Mao L; Carr A; Cysique LA, 2023, 'Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not', eClinicalMedicine, 56, pp. 101792, http://dx.doi.org/10.1016/j.eclinm.2022.101792

Yu X; Lobo JD; Sundermann E; Baker DJ; Tracy RP; Kuchel GA; Stephenson KE; Letendre SL; Brew B; Cysique LA; Dale SK; Wallen C; Kunisaki KM; Guaraldi G; Milic J; Winston A; Moore DJ; Margolick JB; Erlandson KM, 2023, 'Current Challenges and Solutions for Clinical Management and Care of People with HIV: Findings from the 12th Annual International HIV and Aging Workshop', AIDS Research and Human Retroviruses, 39, pp. 1 - 12, http://dx.doi.org/10.1089/aid.2022.0079

Speck P; Mackenzie J; Bull RA; Slobedman B; Drummer H; Fraser J; Herrero L; Helbig K; Londrigan S; Moseley G; Prow N; Hansman G; Edwards R; Ahlenstiel C; Abendroth A; Tscharke D; Hobson-Peters J; Kriiger-Loterio R; Parry R; Marsh G; Harding E; Jacques DA; Gartner MJ; Lee WS; McAuley J; Vaz P; Sainsbury F; Tate MD; Sinclair J; Imrie A; Rawlinson S; Harman A; Carr JM; Monson EA; Hibma M; Mahony TJ; Tu T; Center RJ; Shrestha LB; Hall R; Warner M; Ward V; Anderson DE; Eyre NS; Netzler NE; Peel AJ; Revill P; Beard M; Legione AR; Spencer AJ; Idris A; Forwood J; Sarker S; Purcell DFJ; Bartlett N; Deerain JM; Brew BJ; Asgari S; Farrell H; Khromykh A; Tuipulotu DE; Anderson D; Mese S; Tayyar Y; Edenborough K; Uddin JM; Hussain A; Daymond CJI; Agius J; Johnson KN; Shirmast P; Abedinzadeshahri M; MacDiarmid R; Ashley CL; Laws J; Furfaro LL; Burton TD; Johnson SMR; Telikani Z; Petrone M; Roby JA; Samer C; Suhrbier A; Van Der Kamp A; Cunningham A; Donato C; Mahar J; Black WD; Vasudevan S; Lenchine R; Spann K; Rawle DJ; Rudd P; Neil J; Kingston R; Newsome TP; Kim KW; Mak J; Lowry K; Bryant N, 2023, 'Statement in Support of: “Virology under the Microscope-a Call for Rational Discourse”', Journal of Virology, 97, http://dx.doi.org/10.1128/jvi.00451-23

Goodkin K; Evering TH; Anderson AM; Ragin A; Monaco CL; Gavegnano C; Avery RJ; Rourke SB; Cysique LA; Brew BJ, 2023, 'The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment', Frontiers in Cellular Neuroscience, 17, http://dx.doi.org/10.3389/fncel.2023.1130938

Jakabek D; Brew BJ; Cysique LA, 2023, '42 White matter injury is driven by HIV duration, immune and vascular factors in virally suppressed people living with HIV: a longitudinal diffusion imaging study', Journal of the International Neuropsychological Society, 29, pp. 915 - 916, http://dx.doi.org/10.1017/s1355617723011244

Zeng G; Krishnamurthy S; Pires AS; Guller A; Tun N; Chaganti J; Lockart I; Montagnese S; Brew B; Guillemin G; Danta M; Heng B, 2023, 'Activation of the kynurenine pathway potentially underlies neurodegeneration in patients with covert hepatic encephalopathy', JOURNAL OF HEPATOLOGY, 78, pp. S263 - S264

Anesten B; Zetterberg H; Nilsson S; Brew BJ; Fuchs D; Price RW; Gisslen M; Yilmaz A, 2022, 'Correction: Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection (BMC Neurology, (2021), 21, 1, (494), 10.1186/s12883-021-02527-8)', BMC Neurology, 22, http://dx.doi.org/10.1186/s12883-022-02725-y

Suzuki K; Zaunders J; Gates TM; Levert A; Butterly S; Liu Z; Ishida T; Palmer S; Rae CD; Jugé L; Cysique LA; Brew BJ, 2022, 'Elevation of cell-associated HIV-1 transcripts in CSF CD4+ T cells, despite effective antiretroviral therapy, is linked to brain injury', Proceedings of the National Academy of Sciences of the United States of America, 119, pp. 1 - 11, http://dx.doi.org/10.1073/pnas.2210584119

Cochrane CR; Angelovich TA; Byrnes SJ; Waring E; Guanizo AC; Trollope GS; Zhou J; Vue J; Senior L; Wanicek E; Eddine JJ; Gartner MJ; Jenkins TA; Gorry PR; Brew BJ; Lewin SR; Estes JD; Roche M; Churchill MJ, 2022, 'Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART', Annals of Neurology, 92, pp. 532 - 544, http://dx.doi.org/10.1002/ana.26456

Hernández Cordero AI; Yang CX; Yang J; Li X; Horvath S; Shaipanich T; MacIsaac J; Lin D; McEwen L; Kobor MS; Guillemi S; Harris M; Lam W; Lam S; Obeidat M; Novak RM; Hudson F; Klinker H; Dharan N; Montaner J; Man SFP; Kunisaki K; Sin DD; Leung JM; Baker JV; Duprez D; Carr A; Hoy J; Dolan M; Telenti A; Grady C; Matthews G; Rockstroh J; Belloso WH; Kagan JM; Wright E; Brew B; Price RW; Robertson K; Cysique L; Connett JE; Niewoehner DE; Endpoint Review Committee ; Lifson A; Davey RT; Gatell JM; Pedersen C; Prineas R; Worley J, 2022, 'The relationship between the epigenetic aging biomarker “grimage” and lung function in both the airway and blood of people living with HIV: An observational cohort study', eBioMedicine, 83, http://dx.doi.org/10.1016/j.ebiom.2022.104206

Ulfhammer G; Edn A; Antinori A; Brew BJ; Calcagno A; Cinque P; De Zan V; Hagberg L; Lin A; Nilsson S; Oprea C; Pinnetti C; Spudich S; Trunfio M; Winston A; Price RW; Gissln M, 2022, 'Cerebrospinal Fluid Viral Load Across the Spectrum of Untreated Human Immunodeficiency Virus Type 1 (HIV-1) Infection: A Cross-Sectional Multicenter Study', Clinical Infectious Diseases, 75, pp. 493 - 502, http://dx.doi.org/10.1093/cid/ciab943

Pires AS; Sundaram G; Heng B; Krishnamurthy S; Brew BJ; Guillemin GJ, 2022, 'Recent advances in clinical trials targeting the kynurenine pathway', Pharmacology and Therapeutics, 236, http://dx.doi.org/10.1016/j.pharmthera.2021.108055

Aung HL; Gates TM; Mao L; Brew BJ; Rourke SB; Cysique LA, 2022, 'Abnormal cognitive aging in people with HIV: evidence from data integration between two countries’ cohort studies', AIDS, 36, pp. 1171 - 1179, http://dx.doi.org/10.1097/QAD.0000000000003230

Singh B; Lant S; Cividini S; Cattrall JWS; Goodwin LC; Benjamin L; Michael BD; Khawaja A; Matos ADMB; Alkeridy W; Pilotto A; Lahiri D; Rawlinson R; Mhlanga S; Lopez EC; Sargent BF; Somasundaran A; Tamborska A; Webb G; Younas K; Al Sami Y; Babu H; Banks T; Cavallieri F; Cohen M; Davies E; Dhar S; Modol AF; Farooq H; Harte J; Hey S; Joseph A; Karthikappallil D; Kassahun D; Lipunga G; Mason R; Minton T; Mond G; Poxon J; Rabas S; Soothill G; Zedde M; Yenkoyan K; Brew B; Contini E; Cysique L; Zhang X; Maggi P; van Pesch V; Lechien J; Saussez S; Heyse A; Brito Ferreira ML; Soares CN; Elicer I; Eugenín-Von Bernhardi L; Reyes WÑ; Yin R; Azab MA; Abd-Allah F; Elkady A; Escalard S; Corvol JC; Delorme C; Tattevin P; Bigaut K; Lorenz N; Hornuss D; Hosp J; Rieg S; Wagner D; Knier B; Lingor P; Winkler AS; Sharifi-Razavi A; Moein ST; Seyed Alinaghi SA; Jamali Moghadam Siahkali S; Morassi M; Padovani A; Giunta M; Libri I; Beretta S; Ravaglia S; Foschi M; Calabresi P; Primiano G; Servidei S; Mercuri NB; Liguori C; Pierantozzi M; Sarmati L; Boso F; Garazzino S; Mariotto S; Patrick KN; Costache O; Pincherle A; Klok FA; Meza R, 2022, 'Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis', PLoS ONE, 17, http://dx.doi.org/10.1371/journal.pone.0263595

Jakabek D; Rae CD; Brew BJ; Cysique LA, 2022, 'Brain aging and cardiovascular factors in HIV: A longitudinal volume and shape MRI study', AIDS, 36, pp. 785 - 794, http://dx.doi.org/10.1097/QAD.0000000000003165

Back to profile page